radnet inc (RDNT) Related Bloomberg News

radnet inc (RDNT) Related Businessweek News

No Related Businessweek News Found

radnet inc (RDNT) Details

RadNet, Inc. provides outpatient diagnostic imaging services in the United States. It offers various imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures. The company also provides teleradiology services for remote interpretation of images on behalf of radiology groups, hospitals, and imaging center customers. As of November 6, 2014, it operated a network of 263 owned and/or operated outpatient imaging centers primarily in California, Maryland, Delaware, New Jersey, New York, and Rhode Island. The company was founded in 1985 and is headquartered in Los Angeles, California.

radnet inc (RDNT) Key Developments

RadNet Seeks Acquisitions

Dec 31 14

RadNet, Inc. (NasdaqGM:RDNT) is looking for acquisition opportunities. RadNet filed a $200 million mixed securities shelf offering and net proceeds from the $200 million offering for general corporate purposes, which may include working capital, capital expenditures, acquisitions and refinancing or repayment of debt.

RadNet, Inc. expected to report Fiscal Year 2014 results on March 3, 2015. This event was calculated by Capital IQ (Created on November 21, 2014).

Nov 21 14

RadNet, Inc. expected to report Fiscal Year 2014 results on March 3, 2015. This event was calculated by Capital IQ (Created on November 21, 2014).

All Med Deploys eRAD PACS

Nov 18 14

All Med has deployed eRAD PACS as part of its overall strategy to bring quality medical treatment to patients. eRAD, a subsidiary of RadNet, Inc. installed its PACS on a virtualized/cloud based infrastructure for All Med. The eRAD system enables the practice to manage a distributed network of acquisition sites as well as off-site radiologists. Underscoring the strength of its distributed architecture, eRAD provides flexible viewing options for All Med. "eRAD's HTML5 viewer allows to view studies across any platform--not necessarily for diagnostic purposes but so that can get access to it from anywhere.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.